Advisors Capital Management LLC raised its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 3.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,382,935 shares of the real estate investment trust's stock after purchasing an additional 73,281 shares during
Cinctive Capital Management LP lifted its holdings in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 31.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 184,001 shares of the real estate investment trust's stock after purchasing an additional 43,669
Peakstone Realty Trust (NYSE: PKST - Get Free Report) and Sabra Healthcare REIT (NASDAQ: SBRA - Get Free Report) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a summary
Engineers Gate Manager LP sold 1,513,777 shares of Sabra Health Care REIT (SBRA) Quarter-end position value decreased by $26.85 million, reflecting both trading and price movement effects Transaction represented a 0.33% change in fund's 13F assets under management Post-trade, the fund holds 4,544,219 shares valued at $86.07 million The position now accounts for 1.02% of 13F AUM, placing it outside the fund's top five holdings
Sabra Health Care REIT, Inc. (SBRA) Q4 2025 Earnings Call Transcript
My update on Sabra Health Care REIT upgrades it to a strong buy. Although technical indicators point to a hold, several fundamentals drive the needle into the highly bullish range, particularly portfolio growth and macro demand in this niche of senior care. AFFO dividend coverage is adequate, though the payout ratio is slightly elevated at around 81%.
Sabra Health Care REIT presents a compelling value-income opportunity, offering a 6.4% yield and robust fundamentals. SBRA's SHOP segment drives growth, with same-store NOI up 13.3% and significant new investments targeting a 40% SHOP NOI mix. It received an investment-grade rating, has safe leverage, and has no debt maturities until 2027, supporting dividend safety.
Sabra Health Care REIT, Inc. ( SBRA ) Q3 2025 Earnings Call November 6, 2025 1:00 PM EST Company Participants Lukas Hartwich - Executive Vice President of Finance Rick Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Darrin Smith - Executive Vice President of Investments Michael Costa - Executive VP, CFO & Secretary Conference Call Participants Farrell Granath - BofA Securities, Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division William John Kilichowski - Wells Fargo Securities, LLC, Research Division Seth Bergey - Citigroup Inc., Research Division Juan Sanabria - BMO Capital Markets Equity Research Richard Anderson - Cantor Fitzgerald & Co., Research Division Alec Feygin - Robert W. Baird & Co. Incorporated, Research Division Michael Stroyeck - Green Street Advisors, LLC, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Presentation Operator Good day, everyone.
The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.38 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.37 per share a year ago.
Sabra (SBRA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Sabra Health Care REIT, Inc. (NASDAQ:SBRA ) Q2 2025 Earnings Conference Call August 5, 2025 1:00 PM ET Company Participants Lukas Michael Hartwich - Executive Vice President of Finance Michael Lourenco Costa - Executive VP, CFO & Secretary Richard K. Matros - Chairman, President & CEO Talya Nevo-Hacohen - Executive VP, Chief Investment Officer & Treasurer Conference Call Participants Alec Gregory Feygin - Robert W.